19 of 121 unique stocks in common · Jaccard: 15.7%
A weighted portfolio overlap of 37.34% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹37.34 is allocated to the exact same companies at the same relative proportions. The schemes share 19 common holdings.
The largest overlapping asset in their portfolios is HDFC Bank, which commands a weight of 6.33% in Franklin India Multi-Factor Fund and 7.23% in Templeton India Value Fund. Holding both schemes increases your concentration in HDFC Bank rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Franklin | in Templeton |
|---|---|---|
| HDFC BankBanks | 6.33% | 7.23% |
| Reliance IndustriesPetroleum Products | 5.11% | 6.01% |
| ICICI BankBanks | 4.63% | 4.67% |
| InfosysIT - Software | 2.94% | 3.45% |
| State Bank of IndiaBanks | 2.09% | 2.66% |
| ITCDiversified FMCG | 2.07% | 2.20% |
| NTPCPower | 1.92% | 2.04% |
| Axis BankBanks | 1.90% | 6.78% |
| Tata Consultancy ServicesIT - Software | 1.35% | 4.01% |
| Tata Motors Passenger VehiclesAutomobiles | 1.30% | 2.08% |
| HCL TechnologiesIT - Software | 1.29% | 1.33% |
| Power Grid Corporation of IndiaPower | 1.10% | 1.60% |
| Maruti Suzuki IndiaAutomobiles | 1.03% | 3.27% |
| Tata SteelFerrous Metals | 1.00% | 2.49% |
| Dr. Reddy's LaboratoriesPharmaceuticals & Biotechnology | 0.98% | 1.87% |
| Oil & Natural Gas CorporationOil | 0.93% | 3.82% |
| RECFinance | 0.86% | 2.21% |
| Akums Drugs And PharmaceuticalsPharmaceuticals & Biotechnology | 0.28% | 1.51% |
| Bharat Petroleum CorporationPetroleum Products | 0.21% | 1.07% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.